UNHG:NASDAQLeverage Shares 2X Long UNH Daily ETF Analysis
Data as of 2026-06-18 - not real-time
$21.35
Latest Price
8/10Risk
Risk Level: High
Executive Summary
UNHG is a very young (launched July 2025) 2×‑leveraged single‑stock ETF that tracks UnitedHealth Group. The 20‑day SMA sits comfortably above the 50‑day and 200‑day SMAs, confirming a bullish price crossover, while the broader market sentiment is in the "Extreme Greed" zone. Momentum indicators are mixed: RSI is around the mid‑50s, suggesting no overbought condition, but the MACD histogram has turned slightly negative, hinting at short‑term bearish pressure.
The fund carries a high beta of ~1.3 and a 30‑day volatility exceeding 50%, amplified by the 2× leverage, and its historical max drawdown approaches 61%. Expense ratio is 0.77% and there is no tracking error or premium/discount, but the leveraged daily reset structure makes it unsuitable for long‑term holding despite a solid YTD gain of ~15%.
The fund carries a high beta of ~1.3 and a 30‑day volatility exceeding 50%, amplified by the 2× leverage, and its historical max drawdown approaches 61%. Expense ratio is 0.77% and there is no tracking error or premium/discount, but the leveraged daily reset structure makes it unsuitable for long‑term holding despite a solid YTD gain of ~15%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price pullback from previous close while SMA trend remains bullish
- Slightly bearish MACD histogram suggesting near‑term downside pressure
- Increasing volume supports a potential bounce but volatility remains elevated
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained bullish SMA alignment and strong YTD performance
- High beta and leverage can amplify upside in a rising UNH environment
- Extreme greed sentiment and rising volume indicate market enthusiasm
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Leveraged daily reset leads to decay over extended periods
- Historical max drawdown of over 60% underscores tail‑risk
- Single‑stock concentration makes the fund vulnerable to company‑specific shocks
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.77%
AUM$119.0M
Inception Date2025-07-21
Avg Daily Volume1,125,940
Premium/Discount0.00%
Tracking Error0.00%
Technical Analysis
TrendBullish
RSI56.9
Support$18.77
Resistance$23.00
MA 20$20.68
MA 50$18.66
MA 200$17.36
MACDBearish
VolumeIncreasing
Fear & Greed Index91.04
Risk Assessment
Beta1.31
Volatility51.51%
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.